Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience.

Değertekin, Bülent; Demir, Mehmet; Akarca, Ulus; Kani, Haluk; Üçbilek, Enver; Yıldırım, Emre; Güzelbulut, Fatih; Balkan, Ayhan; Vatansever, Sezgin; Danış, Nilay; Demircan, Melek; Soylu, Aliye; Yaras, Serkan; Kartal, Aysun; Kefeli, Ayşe; Gündüz, Feyza; Yalçın, Kendal; Erarslan, Elife; Aladağ, Murat; Harputluoğlu, Murat; Özakyol, Ayşegül; Temel, TUNCER; Akarsu, Mesut; Sümer, Hale; Akın, Mete; Albayrak, Bülent; Sen, İlker; Alkım, Hüseyin; Uyanıkoğlu, Ahmet; Irak, Kader; Öztaşkın, Sinem; Uğurlu, Çağrı; Güneş, Şevkican; Gürel, Selim; Nuriyev, Kenan; İnci, İsmail; Kaçar, Sabite; Dinçer, Dinç; Doğanay, Levent; Göktürk, Hüseyin; Mert, Ali; Coşar, Arif; Dursun, Hakan; Atalay, Roni; Akbulut, Sabiye; Balkan, Yasemin; Koklu, Hayrettin; Şimşek, Halis; Özdoğan, Osman; Çoban, Mehmet

doi:10.5152/tjg.2020.20696

Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience.

Değertekin B., Demir M., Akarca U. S., Kani H. T., Üçbilek E., Yıldırım E., ...More

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, vol.31, pp.883-893, 2020 (SCI-Expanded)

Publication Type: Article / Article
Volume: 31
Publication Date: 2020
Doi Number: 10.5152/tjg.2020.20696
Journal Name: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
Page Numbers: pp.883-893
Keywords: HCV, treatment, direct-acting antiviral, Turkey, SUSTAINED VIROLOGICAL RESPONSE, ACTING ANTIVIRAL THERAPY, HEPATOCELLULAR-CARCINOMA, HCV, INFECTION, RIBAVIRIN, CIRRHOSIS, TURKEY
Eskisehir Osmangazi University Affiliated: Yes

Abstract

Background/Aims: This study aimed to evaluate the real-life efficacy and tolerability of direct-acting antiviral treatments for patients with chronic hepatitis C (CHC) with/without cirrhosis in the Turkish population.